AVTX is the official Nasdaq stock exchange ticker symbol for Avalo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing targeted therapeutics and monoclonal antibodies. Its research and clinical pipeline are dedicated to treating severe immune-mediated inflammatory diseases and autoimmune conditions with significant remaining unmet medical needs through advanced biological pathways.